Big biotech, UCs launch $53M effort targeting Alzheimer's, other brain diseases
February 25, 2021 at 17:38 PM EST
The Alliance for Therapies in Neuroscience will use CRISPR genome-editing technology and other advances to dive deeper into biomarkers and potential therapies for Alzheimer's, Parkinson's, Huntington's, autism, ALS and more.
